
Ro 09-0680
CAS No. 87112-49-0
Ro 09-0680( —— )
Catalog No. M34400 CAS No. 87112-49-0
Ro 09-0680, a compound derived from Salvia miltiorrhiza, is a potent inhibitor of collagen-induced platelet aggregation in rabbits with potential anti-inflammatory activity for the study of cardiovascular disease.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 445 | Get Quote |
![]() ![]() |
5MG | 686 | Get Quote |
![]() ![]() |
25MG | 1398 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameRo 09-0680
-
NoteResearch use only, not for human use.
-
Brief DescriptionRo 09-0680, a compound derived from Salvia miltiorrhiza, is a potent inhibitor of collagen-induced platelet aggregation in rabbits with potential anti-inflammatory activity for the study of cardiovascular disease.
-
DescriptionRo 09-0680, a compound derived from Salvia miltiorrhiza, is a potent inhibitor of collagen-induced platelet aggregation in rabbits with potential anti-inflammatory activity for the study of cardiovascular disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number87112-49-0
-
Formula Weight264.32
-
Molecular FormulaC18H16O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(=O)C2=C(C=CC3=C2C=CC=C3C)C=C1C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
C14 Ceramide (d18:1/...
C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's research.
-
Regelidine
Regelidine is a natural product from Tripterygium regelii.
-
Safflower-yellow
Safflower yellow is extracted from the flowers of the plant safflower (Carthamus tinctorius) and as the traditional Chinese medicine it has been extensively used for the treatment of cardio cerebrovascular diseases.